Peter Thiel-backed psychedelic start-up's shares pop in Wall Street debut By: CNBC.com News June 18, 2021 at 14:30 PM EDT The German biotech's initial public offering was priced Thursday night at $15 per share, the high end of the expected range. Read More >> Related Stocks: Renaissance IPO ETF Renaissance International IPO ETF